Nozza S - Search Results

1

'Multidrug-resistant Mycoplasma genitalium urethritis: successful eradication with sequential therapy.

Raccagni AR, Bruzzesi E, Spagnuolo V, Canetti D, Castagna A, Nozza S. Raccagni AR, et al. Among authors: nozza s. Sex Transm Infect. 2023 Feb;99(1):77. doi: 10.1136/sextrans-2022-055678. Epub 2022 Dec 6. Sex Transm Infect. 2023. PMID: 36601744 No abstract available.

2

Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients.

Hasson H, Gianotti N, Danise A, Seminari E, Boeri E, Nozza S, Castagna A, Lazzarin A. Hasson H, et al. Among authors: nozza s. AIDS. 2004 Jan 2;18(1):123-7. doi: 10.1097/00002030-200401020-00016. AIDS. 2004. PMID: 15090838

3

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.

Nozza S, Galli L, Visco F, Soria A, Canducci F, Salpietro S, Gianotti N, Bigoloni A, Torre LD, Tambussi G, Lazzarin A, Castagna A. Nozza S, et al. AIDS. 2010 Mar 27;24(6):924-8. doi: 10.1097/QAD.0b013e3283372d76. AIDS. 2010. PMID: 20154578

4

Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients.

Gianotti N, Visco F, Galli L, Barda B, Piatti P, Salpietro S, Bigoloni A, Vinci C, Nozza S, Gallotta G, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: nozza s. HIV Med. 2011 Feb;12(2):109-17. doi: 10.1111/j.1468-1293.2010.00860.x. HIV Med. 2011. PMID: 20629770 Free article.

5

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.

Canducci F, Barda B, Ceresola E, Spagnuolo V, Sampaolo M, Boeri E, Nozza S, Cossarin F, Galli A, Gianotti N, Castagna A, Lazzarin A, Clementi M. Canducci F, et al. Among authors: nozza s. Clin Microbiol Infect. 2011 Jun;17(6):928-34. doi: 10.1111/j.1469-0691.2010.03375.x. Epub 2010 Nov 5. Clin Microbiol Infect. 2011. PMID: 20854427 Free article.

6

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism.

Siccardi M, D'Avolio A, Nozza S, Simiele M, Baietto L, Stefani FR, Moss D, Kwan WS, Castagna A, Lazzarin A, Calcagno A, Bonora S, Back D, Di Perri G, Owen A. Siccardi M, et al. Among authors: nozza s. Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb. Pharmacogenet Genomics. 2010. PMID: 21217360 Clinical Trial.

7

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.

Nozza S, Canducci F, Galli L, Cozzi-Lepri A, Capobianchi MR, Ceresola ER, Narciso P, Libertone R, Castelli P, Moioli M, D'Arminio Monforte A, Castagna A; ICONA Foundation. Nozza S, et al. J Antimicrob Chemother. 2012 May;67(5):1224-7. doi: 10.1093/jac/dkr600. Epub 2012 Jan 31. J Antimicrob Chemother. 2012. PMID: 22298348

8

Immune recovery and T cell subset analysis during effective treatment with maraviroc.

Cossarini F, Galli A, Galli L, Bigoloni A, Salpietro S, Vinci C, Della Torre L, Gianotti N, Spagnuolo V, Lazzarin A, Castagna A, Nozza S. Cossarini F, et al. Among authors: nozza s. J Antimicrob Chemother. 2012 Oct;67(10):2474-8. doi: 10.1093/jac/dks216. Epub 2012 Jun 7. J Antimicrob Chemother. 2012. PMID: 22678730

9

Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.

Nozza S, Pogliaghi M, Chiappetta S, Spagnuolo V, Fontana G, Razzari C, Tambussi G, Faioni EM. Nozza S, et al. PLoS One. 2012;7(6):e37032. doi: 10.1371/journal.pone.0037032. Epub 2012 Jun 8. PLoS One. 2012. PMID: 22715361 Free PMC article.

10

Monotherapy with atazanavir as a simplification strategy: results from an observational study.

Cossarini F, Salpietro S, Galli L, Gianotti N, Nozza S, Spagnuolo V, Hasson H, Bossolasco S, Lazzarin A, Tambussi G, Castagna A. Cossarini F, et al. Among authors: nozza s. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e101-3. doi: 10.1097/QAI.0b013e318258bf3c. J Acquir Immune Defic Syndr. 2012. PMID: 22728751 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page